Form 8-K - Current report:
SEC Accession No. 0001654954-24-010399
Filing Date
2024-08-13
Accepted
2024-08-13 09:24:59
Documents
16
Period of Report
2024-08-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm   iXBRL 8-K 27847
2 PRESS RELEASE ndra_ex991.htm EX-99.1 15841
  Complete submission text file 0001654954-24-010399.txt   175028

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20240812.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20240812_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20240812_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20240812_pre.xml EX-101.PRE 9275
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20240812_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT ndra_8k_htm.xml XML 3903
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 241199105
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)